Russia: COVID-19 Vaccine Trials Produce Successful Results
A medical research institute in Russia has claimed to have successfully completed clinical trials of a coronavirus (COVID-19) vaccine that they have developed.
This is according to Elena Smolyarchuk – head of the Centre for Clinical Research on Medications at Sechenov University – who revealed the news to a Russian media outlet on Sunday, 12 July.
Smolyarchuk said: “The research has been completed and it proved that the vaccine is safe. The volunteers will be discharged on July 15 and July 20 [sic].”
Human trials of the COVID-19 vaccine – which is being developed by Gamaleya National Research Centre for Epidemiology and Microbiology – began on 18 June. Nine volunteers received one dose, while another nine were injected with the prospective booster dose.
An additional 20 volunteers were administered with the vaccine on 23 June.
After showing positive results and being discharged, these 38 volunteers will be monitored for six months.
Russia’s medical authorities hope to introduce the vaccine to public circulation in mid-August.